Ad-hoc disclosure of December 12, 2007

Munich, Dec 12, 2007

At today’s regular meeting of Wacker Chemie AG’s supervisory board, important decisions were made to ensure the continuity of the leadership of the company. Dr. Karl Heinz Weiss, Chairman of the Supervisory Board, who will reach the age limit for supervisory board members will no longer be available after the next upcoming Annual General Meeting on May 8th, 2008. At the same time Dr. Peter-Alexander Wacker will step down from his function as President and Chief Executive Officer of Wacker Chemie AG and will run for the position of the Chairman of the Supervisory Board. The Supervisory Board welcomes the decisions and sees the long term strategic direction of the company assured.

Dr. Rudolf Staudigl will be successor to Peter-Alexander Wacker as President and Chief Executive Officer of Wacker Chemie AG. He is a member of WACKER‘s Management Board since 1995. During today’s session, the Supervisory Board prolonged Staudigl’s contract for another 5 years. Staudigl will assume the role of President & CEO after the next Annual General Meeting.

Dr. Karl Heinz Weiss will continue to serve as the Speaker of the Board for WACKER’s majority shareholder, Dr. Alexander Wacker Familiengesellschaft mbH.

Contact

Wacker Chemie AG
Hanns-Seidel-Platz 4
D-81737 München

Jörg Hoffmann
Tel. +49 89 6279-1633
Email investor.relations@wacker.com

Additional Information

ISIN: DE000WCH8881
WKN: WCH888
Deutsche Boerse: WCH
Ticker Bloomberg CHM/WCK.GR
Ticker Reuters CHE/WCHG.DE
Listing: Frankfurt Stock Exchange (Frankfurter Wertpapierbörse), Official Market (Prime Standard)

Disclaimer:

This publication contains forward-looking statements based on assumptions and estimates of WACKER’s Executive Board. Although we assume the expectations in these forward-looking statements are realistic, we cannot guarantee they will prove to be correct. The assumptions may harbor risks and uncertainties that may cause the actual figures to differ considerably from the forward-looking statements. Factors that may cause such discrepancies include changes in the economic and business environment, variations in exchange and interest rates, the introduction of competing products, lack of acceptance for new products or services, and changes in corporate strategy. WACKER does not plan to update its forward-looking statements, nor does it assume the obligation to do so.

This document includes supplemental financial measures (not clearly defined in the applicable financial reporting framework) that are or may be alternative performance measures (APM). These supplemental financial measures should not be viewed in isolation or as alternatives to measures of WACKER’s net assets and financial positions or results of operations as presented in accordance with the applicable financial reporting framework in its Consolidated Financial Statements. Other companies that report or describe similarly titled alternative performance measures may calculate them differently. Explanations of financial measures used can be found in the Annual Report 2017 of Wacker Chemie AG which is available for download under www.wacker.com.